We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

151 hedge funds and large institutions have $1.66B invested in DIPLOMAT PHARMACY, INC. in 2015 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 66 increasing their positions, 30 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more call options, than puts

Call options by funds: $8.11M | Put options by funds: $2.84M

120% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 30

95% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 22

50% more capital invested

Capital invested by funds: $1.1B → $1.66B (+$555M)

16% more funds holding

Funds holding: 130151 (+21)

Holders
151
Holders Change
+21
Holders Change %
+16.15%
% of All Funds
3.96%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
43
Increased
66
Reduced
30
Closed
22
Calls
$8.11M
Puts
$2.84M
Net Calls
+$5.27M
Net Calls Change
+$3.15M
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$19.7M +$3.63M +116,195 +25%
Cambridge Investment Research Advisors
27
Cambridge Investment Research Advisors
Iowa
$18M +$14.8M +475,961 +973%
CCI
28
Columbus Circle Investors
$15M +$4.55M +145,898 +50%
SCP
29
Sandhill Capital Partners
New York
$12.6M +$5.7M +182,752 +98%
Brown Advisory
30
Brown Advisory
Maryland
$12.6M +$11.5M +368,773 New
OAM
31
Oberweis Asset Management
Illinois
$12M +$2.29M +73,466 +27%
CCM
32
Cupps Capital Management
Illinois
$9.05M -$604K -19,368 -7%
Asset Management One
33
Asset Management One
Japan
$8.86M +$3.71M +118,756 +86%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$8.37M -$1.36M -43,557 -15%
RFC
35
Russell Frank Company
Washington
$7.99M +$392K +12,553 +6%
JP Morgan Chase
36
JP Morgan Chase
New York
$7.94M +$2.49M +79,838 +52%
Geode Capital Management
37
Geode Capital Management
Massachusetts
$7.5M +$411K +13,183 +6%
PC
38
Paulson & Co
New York
$7.19M +$6.55M +210,000 New
TG
39
TCW Group
California
$7.15M +$2.27M +72,637 +53%
Ohio Public Employees Retirement System (OPERS)
40
Ohio Public Employees Retirement System (OPERS)
Ohio
$6.88M +$1.01M +32,400 +19%
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$6.84M
GIP
42
Granite Investment Partners
California
$6.46M -$103K -3,313 -2%
Marshall Wace
43
Marshall Wace
United Kingdom
$6.34M +$5.79M +185,427 New
FAM
44
Fred Alger Management
New York
$5.51M -$5.49M -176,103 -52%
Bank of America
45
Bank of America
North Carolina
$5.39M +$3.15M +100,884 +179%
BIM
46
BlackRock Investment Management
Delaware
$4.15M +$14.4K +460 +0.4%
LOAMS
47
Lombard Odier Asset Management (Switzerland)
Switzerland
$4.11M +$3.74M +120,000 New
TCIM
48
TIAA CREF Investment Management
New York
$4.02M -$2.26M -72,557 -38%
PC
49
Pier Capital
Connecticut
$3.88M -$3.47M -111,072 -49%
BCM
50
Bridgeway Capital Management
Texas
$3.85M +$2.05M +65,800 +141%

DPLO Hedge Fund Activity: Q4 2015 in Review

151 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2015, worth a combined $1.66B — up 50% from $1.1B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new DPLO positions and 22 closed out — a net gain of 21 holders — while 66 added to existing stakes and 30 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $68M. The largest seller was Fidelity Investments, cutting an estimated $59M.

  • 151 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2015, up from 130 in Q3 2015.
  • Funds reported $1.66B of DIPLOMAT PHARMACY, INC. stock for Q4 2015, up 50% quarter-over-quarter.
  • 43 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2015 and 22 closed out, a net change of +21 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2015 was Janus Henderson Investors US, an estimated $68M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q4 2015 was Fidelity Investments, an estimated $59M sold.

Based on aggregated 13F filings for Q4 2015.